Skip to main content
. Author manuscript; available in PMC: 2014 Nov 24.
Published in final edited form as: Clin Cancer Res. 2010 Jul 20;16(15):4057–4065. doi: 10.1158/1078-0432.CCR-10-1093

Table 2.

Immune monitoring summary and clinical outcomes of patients who produced a measureable immune response.

Arm Patient No. Increase in gp100 Tetramer-reactive Cells Increase in CD8+ IFN-γ+ Cells Clinical Status1
Intramuscular 17 + POD
25 gp100280-288 + POD
Particle-Mediated Epidermal Delivery 4 + POD
5 gp100280-288 + NED
9 gp100209-217 +; gp100280-288 + POD
11 + POD
22 + NED
27 gp100280-288 + + NED
1

Abbreviations: NED, no evidence of disease; POD, progression of disease.